Phase 2 Nasopharyngeal Cancinoma (NPC) Clinical Trials
9 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–9 of 9 trials
Recruiting
Phase 2
LDRT Combined With Toripalimab and Chemotherapy for Recurrent/Metastatic NPC
Nasopharangeal CancerNasopharyngeal Cancinoma (NPC)
Sun Yat-sen University55 enrolled1 locationNCT07325539
Recruiting
Phase 1Phase 2
A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers
Squamous Cell CarcinomaAdvanced or Metastatic Squamous Non-Small Cell Lung CancerAdvanced Head and Neck Squamous Cell Carcinoma+4 more
Hummingbird Bioscience398 enrolled20 locationsNCT05910827
Recruiting
Phase 2
Becotatug Vedotin for LA-NPC With a Suboptimal Response to Induction Chemotherapy Combined With Immunotherapy
Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University59 enrolled1 locationNCT07496190
Recruiting
Phase 2
LDRT and Chemoimmunotherapy in NPC With Liver Metastasis
Nasopharyngeal Cancinoma (NPC)
Hunan Cancer Hospital26 enrolled7 locationsNCT06788002
Recruiting
Phase 2
Toripalimab Combined With Different Platinum-Based Induction Chemotherapy Regimens for Locally Advanced Nasopharyngeal Carcinoma
Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University243 enrolled4 locationsNCT07362979
Recruiting
Phase 2
Tislelizumab Combined With Capecitabine for Nasopharyngeal Carcinoma With Residual EBV DNA After Radiotherapy
Nasopharyngeal Cancinoma (NPC)
Fudan University76 enrolled1 locationNCT07067268
Recruiting
Phase 2
SBRT Combined With Nimotuzumab and Tislelizumab for Oligoprogressive Recurrent/Metastatic Nasopharyngeal Carcinoma After Failure of Immunotherapy
ImmunotherapySBRTNasopharyngeal Cancinoma (NPC)
The First Affiliated Hospital of Xiamen University20 enrolled2 locationsNCT06676722
Recruiting
Phase 1Phase 2
EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal Carcinoma
Nasopharyngeal Cancinoma (NPC)Metastatic Nasopharyngeal CarcinomaRecurrent Nasopharynx Carcinoma
Sun Yat-Sen University Cancer Center148 enrolled1 locationNCT06802835
Recruiting
Phase 2Phase 3
Sodium Bicarbonate for Reducing Radiation-Induced Oral Mucositis in Nasopharyngeal Carcinoma.
Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University196 enrolled1 locationNCT06854510